Vol 8, No 1 (2012)

Cover Page

DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS

PRIMARY TESTICULAR NON-HODGKIN’S LYMPHOMAS

Sotnikova O.P., Sorokin E.N., Poddubnaya I.V.

Abstract

Primary testis lymphoma is a rare disease, that accounts for 7 % of all testis neoplasms, 12 % of all extranodal lymphomas. In our investigation 62 patients with primary lymphoma of testis were observed. 34 patients (55 %) receved polychemotherapy by antracyclins ± rituximab. 16 patients (25,6 %) were treated by radiochemotherapy. Early appearing recurrence was in 20 cases (57 %) with dissemination in 8 cases. Late recurrence — in 15 (43 %) with dissemination in 5 cases.
Cancer Urology. 2012;8(1):88-93
pages 88-93 views

DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER

RETROSPECTIVE ANALYSIS OF THE RESULTS OF RADICAL CYSTECTOMY IN NON-MUSCLE INVASIVE BLADDER CANCER

Kogan M.I., Vasilyev O.N.

Abstract

The results of treatment were analyzed in 53 patients with high-risk non-muscle invasive bladder cancer (BC), who had undergone radical cystectomy (RCE) and bilateral pelvic lymphadenectomy. Histological hypostaging was noted in 20.7% of the patients; 13.2% of them had regional lymph node metastases, which confirms the problems associated with the accurate determination of a BC stage in clinical stage T1. The predictors of lower cancer-specific survival were identified in patients after RCE for pT1 cancer. In our study, 5- and 10-year cancer-specific survival was 90.5 and 88.6% in cT1 stage and 98.2 and 96.3% in pT1 stage, respectively. The findings strongly suggest that RCE can afford a long-term high cancer-specific survival in patients with non-muscle invasive BC.

Cancer Urology. 2012;8(1):36-42
pages 36-42 views

RETROSPECTIVE ANALYSIS OF THE RESULTS OF RADICAL CYSTECTOMY IN NON-MUSCLE INVASIVE BLADDER CANCER

Kogan M.I., Vasilyev O.N.

Abstract

The results of treatment were analyzed in 53 patients with high-risk non-muscle invasive bladder cancer (BC), who had undergone radical cystectomy (RCE) and bilateral pelvic lymphadenectomy. Histological hypostaging was noted in 20.7% of the patients; 13.2% of them had regional lymph node metastases, which confirms the problems associated with the accurate determination of a BC stage in clinical stage T1. The predictors of lower cancer-specific survival were identified in patients after RCE for pT1 cancer. In our study, 5- and 10-year cancerspecific survival was 90.5 and 88.6% in cT1 stage and 98.2 and 96.3% in pT1 stage, respectively. The findings strongly suggest that RCE can afford a long-term high cancer-specific survival in patients with non-muscle invasive BC.
Cancer Urology. 2012;8(1):43-48
pages 43-48 views

DEVELOPMENT OF THE NOMOGRAM THAT PREDICTS PATHOLOGICAL LYMPH NODE INVOLVEMENT IN BLADDER CANCER PATIENTS BASED ON CLINICAL VARIABLES

Mirylenko L.V., Sukonko O.G., Pravorov A.V., Rolevich A.I., Mavrichev A.S.

Abstract

Objective: to develop nomogram based on clinical variables, that predicts pathological lymph node involvement (рN+) in bladder cancer patients.

Material and methods: We used data of 511 patients with bladder cancer, that have undergone radical cystectomy between 1999 and 2008 at N.N. Alexandrov National Cancer Centre. Mono- and multivariate logistic regression analyses were used for pN+ prediction on preoperative data. Coefficients from logistic regression equation were used to construct the nomogram. Nomogram accuracy was evaluated with concordance index and construction of the calibration plot. Internal validation by bootstrap method with 200 variants of dataset was performed.

Results: We developed nomogram, that includes: clinical stage сТ, tumor grade, tumor macroscopic appearance, and creatinine level. Bootstrap-corrected prognostic accuracy of nomogram was 71,6%, that was 9,4% better than clinical stage accuracy.

Conclusion: utilization of developed nomogram can significantly improve pathologic tumor stage prediction accuracy that may be used to select patients for neoadjuvant chemotherapy.

Cancer Urology. 2012;8(1):49-55
pages 49-55 views

PROGNOSTIC MARKERS OF URINARY BLADDER CANCER RECURRENCE AND LYMPHATIC SPREAD

Pavlov V.N., Izmailov A.A., Izmailova S.M., Urmancev M.F., Ahmadishina L.Z., Alekseev A.V., Zagitov A.R., Kutliarov L.M., Victorova T.V.

Abstract

Treatment results (2005-2009) for patients with surface (n = 104) and invasive (n = 104) urinary bladder carcinoma were analyzed. Molecular genetic analysis of cytochrome gene P450 polymorphous locus carried out: CYP1А1 (A2455G), СYP1A2 (T-2464delT), Glutathione S-transferase: GSTM1 (del), GSTP1 (A313G); DNA reparation: XRCC1 (G28152A) for patients with surface urine bladder carcinoma recurrence, which took place within a year, and for patients with surface urine bladder carcinoma without recurrence within a year. Genotypes associated with surface urine bladder carcinoma one-year recurrence were identified. Furthermore, analysis of these genes polymorphous locsus of patients with invasive urine bladder carcinoma with and without lymphogenic metastases was carried out. Genotypes associated with lyphogenic metastasis risk were identified.

Cancer Urology. 2012;8(1):56-61
pages 56-61 views

DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER

ACTIVE OBSERVATION TACTICS IN PATIENTS WITH KIDNEY NEOPLASMS

Alekseev B.Y., Kalpinskiy A.S.

Abstract

As of now, about 40-60% of the first detected kidney tumors are accidentally diagnosed. These are most often asymptomatic small kidney tumors (SKT) without distant metastases; 15–20% of them are benign. A number of studies have revealed that kidney malignant tumors grow slowly and spread extremely rarely, as evidenced by a histological study. These and other data formed the basis for the active observation tactic that became possible and acceptable in well-selected patients, in elderly patients with SKT and severe comorbidity in particular.

Cancer Urology. 2012;8(1):23-30
pages 23-30 views

THE SPECIFIC FEATURES OF A RESPONSE TO A TYROSINE KINASE INHIBITOR AGAINST DIFFERENT HISTOLOGICAL TYPES OF KIDNEY CANCER (A REVIEW)

Kaprin A.D., Kostin A.A., Alekseev V.V., Varakina A.Y.

Abstract

The paper deals with the results of a clinical trial covering patients with disseminated renal cell carcinoma of different histological types, who had no benefits from previous systemic therapy. The response of different histological types of kidney cancer to therapy with tyrosine kinase inhibitors, to sorafenib in particular, was studied within the trial. The findings strongly suggest that mainly patients with clear-cell renal cell carcinoma could achieve complete or partial remission.
Cancer Urology. 2012;8(1):31-35
pages 31-35 views

REVIEW

THE DIFFERENTIATIVE DIAGNOSIS OF RENAL CYSTS

Seregin A.V., Borzetsovskaya V.V.

Abstract

 Despite the progress of diagnostic possibilities, the interpretation of renal cysts is still difficult and may have false negative results. So far there is no algorithm of renal cysts patients examination and treatment. Further diagnostic process improvement and an exact knowledge of the possibilities of each method are needed. The main factor for choosing the right tactics of treatment and giving the prognosis of the disease is not only the diagnosis, but also the exact gradation of the renal cysts according to the Bosniak classification. 

Cancer Urology. 2012;8(1):102-108
pages 102-108 views

METHODS FOR IDENTIFICATION OF THE ELEMENTS OF THE PROSTATE NEUROVASCULAR BUNDLE (A REVIEW OF LITERATURE)

Ledyaev D.S., Zagainova E.V., Atduyev V.A.

Abstract

With regard to a considerable number of erective dysfunction after radical prostatectomy and a rise in the number of patients concerned with postoperative potency preservation, the identification of neurovascular bundles (NVB) remains an urgent problem. Different NVB imaging procedures exist today; however, there is now no method that is optimal and able to prevent cavernous nerve injury with high probability and reduce the number of complications. The advantages and disadvantages of these procedures should be determined by the long-term functional results of their use, which were assessed in randomized studies.

Cancer Urology. 2012;8(1):109-112
pages 109-112 views

PROSTATE CANCER

RESULTS OF A GOAL-ORIENTED PROSTATE CANCER SCREENING PROGRAM IN THE PENZA REGION

Engalychev F.S., Mironov M.A., Galkina N.G., Galkin A.V., Durdenevsky N.B., Syskova M.A.

Abstract

Prostate cancer (PC) has been recently the most common male cancer disease. At the same time, its incidence is ever increasing. In this connection, PS screening is highly pressing.

Objective: to study and assess the first results of a regional goal-oriented PC screening program in the Penza Region.

Subjects and methods. The regional goal-oriented “Male Health” program for PC screening was launched in the Penza Region in February 2008. The serum level of prostate-specific antigen (PSA) was detected in all 45-to-70-year men who had visited the region’s polyclinics and hospitals for any disease. Digital rectal and transrectal ultrasound studies were additionally performed in patients having the symptoms of lower urinary tract dysfunction. When the PSA level was > 4 ng/ml, multifocal biopsy was made through transperineal and transrectal accesses under ultrasound guidance, by using 12-24 points.

Results. In February 2008 to June 2010, blood was tested for PSA in 55 of 103 patients. In 5910 (10.7%) of them, its level (> 4 ng/ml) was above the allowable limit. Multifocal prostate puncture biopsy was performed in 1695 patients with elevated PSA levels for further examination to rule out PC. The latter was established by the results of biopsy in 737 patients. The percentage of biopsy results positive for cancer was 38.9%. That of PC detected among all the men examined for serum PSA level was 1.3%.

Conclusion. To elaborate programs for the early diagnosis and screening of PC is one of the priorities of the development of oncourology, which can considerably improve the results of treatment for this disease.

Cancer Urology. 2012;8(1):62-65
pages 62-65 views

COMPARATIVE ESTIMATION OF THE PROGNOSTIC VALUE OF THE BASELINE VALUES OF SERUM TESTOSTERONE AND PROSTATE-SPECIFIC ANTIGEN IN PATIENTS WITH SUSPECTED PROSTATE CANCER

Grigoryev M.E., Ermisheva O.M.

Abstract

Prostate cancer (PC) is now one of the most common malignancies in elderly men. The level of prostate-specific antigen (PSA) as the most valuable prognostic tumor marker is estimated for the early detection of PC in practical health care. However, it has no strict specificity for PC and its low and threshold values do not allow prostate neoplasm to be ruled out.

The objective of the investigation was to search for correlations between the level of testosterone, that of PSA, and prostate tissue morphological changes in patients with PC.

Cancer Urology. 2012;8(1):66-71
pages 66-71 views

EXPERIENCE WITH A HISTOSCANNING APPARATUS USED IN THE EARLY DIAGNOSIS OF PROSTATE CANCER

Glybochko P.V., Alyaev Y.G., Amosov A.V., Krupinov G.E., Obukhov A.A., Ganzha T.M., Amosov N.A.

Abstract

In September 2011, the Research Institute of Uronephrology and Human Reproductive Health began to use an apparatus for the early diagnosis of prostate cancer. One hundred and fifty-six studies have been conducted by now. In the examinees, the level of prostate-specific antigen was estimated to be in the range of 1.09 to 209 ng/ml. The results of the studies confirm European data on the sensitivity and specificity of this procedure.

Cancer Urology. 2012;8(1):72-76
pages 72-76 views

THE RATE AND SITE OF LYMPH NODE METASTASES DURING RADICAL PROSTATECTOMY AND EXTENDED LYMPHADENECTOMY IN PATIENTS WITH PROSTATE CANCER

Alekseev B.Y., Nyushko K.M., Vorobyev N.V., Kalpinskiy A.S., Golovashchenko M.P., Frank G.A., Andreeva Y.Y.

Abstract

Prostate cancer (PC) is one of the most common male cancer diseases. Pelvic lymphadenectomy (PLAE) is an important diagnostic stage during both surgery and radiotherapy. The main goal of PLAE is to evaluate the pelvic lymph nodes (LN), which makes it possible to define the prognosis of the disease and to choose the most rational treatment policy. The paper analyzes the results of treating 298 moderate-to highrisk circumscribed and locally advanced PC patients undergoing prostatectomy or extended PLAE at the Department of Oncourology, P.A. Herzen Moscow Oncology Research Institute. The detection rate for LN metastases and their site are estimated and the risk for complications due to extended PLAE analyzed.

Cancer Urology. 2012;8(1):77-81
pages 77-81 views

NEW TECHNOLOGIES IN THE DIAGNOSIS AND REHABILITATION TREATMENT OF DYSURIA AFTER SURGICAL TREATMENT FOR PROSTATE CANCER

Markosyan T.G., Korchazhkina N.B., Nikitin S.S.

Abstract

Cancer Urology. 2012;8(1):82-87
pages 82-87 views

CONGRESSES AND CONFERENCES

МЕРОПРИЯТИЯ РООУ В 2012 Г.

.

Abstract

Мероприятия РООУ в 2012 г.

Cancer Urology. 2012;8(1):115-117
pages 115-117 views

DIFFERENT

ПРЕСС-РЕЛИЗ

.

Abstract

Пресс-релиз
Cancer Urology. 2012;8(1):118
pages 118 views

РЕГИСТРАЦИОННАЯ АНКЕТА УЧАСТНИКА МЕРОПРИЯТИЙ РОССИЙСКОГО ОБЩЕСТВА ОНКОУРОЛОГОВ В 2012 Г.

.

Abstract

РЕГИСТРАЦИОННАЯ АНКЕТА участника мероприятий Российского общества онкоурологов в 2012 г.

Cancer Urology. 2012;8(1):
views

CLINICAL CASE

RESECTION OF THE S-SHAPED CROSSED DYSTOPIC KIDNEY IN A PATIENT WITH RENAL CELL CARCINOMA

Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Vorobyev N.V., Golovashchenko M.P., Chissov V.I.

Abstract

Renal cell carcinoma (RCC) is one of the most urgent topics in modern oncourology. This is attributable to the high morbidity and mortality rates associated with this pathology. Renal dystopia is a rather rare developmental anomaly. The literature data describing cases of the diagnosis and treatment in patients with dystopic kidney malignancies are scarce. Moreover, if a tumor is present in the solitary dystopic kidney, it is often extremely difficult to perform an organ-saving operation for a number of features of the anatomic structure of the dystopic kidney and its vascular architectonics. The paper describes a clinical case of S-shaped crossed dystopic kidney resection in a patient with RCC.

Cancer Urology. 2012;8(1):94-99
pages 94-99 views

TESTICULAR CAPILLARY HEMANGIOMA: DESCRIPTION OF A CASE

Markova A.S., Gurariy L.L., Ermilova V.D.

Abstract

The paper describes a clinical case of testicular capillary hemangioma in a 24-year-old man undergone a partial resection of the testis with the intraoperative morphological examination. Testicular capillary hemangioma is a rare benign tumor of a vascular origin, which can be similar to malignant testicular tumors on the clinical presentation, as well as on the imaging methods, in particular to seminoma. The intraoperative histological study can assist in avoiding organ-removing surgical interventions in diagnostically ambiguous cases if a benign testicular tumor is diagnosed.

Cancer Urology. 2012;8(1):100-101
pages 100-101 views

LECTURE

INTRAVESICAL BCG THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER

Figurin K.M.

Abstract

The paper considers the state-of-the-art of BCG vaccine treatment for non-muscle invasive bladder cancer. It gives data on the meta-analyses of foreign studies of the efficiency of BCG therapy in this pathology.

Cancer Urology. 2012;8(1):14-22
pages 14-22 views

ANNIVERSARIES

К 70-ЛЕТИЮ СО ДНЯ РОЖДЕНИЯ ЮРИЯ ГЕННАДЬЕВИЧА АЛЯЕВА

Abstract

К 70-летию со дня рождения Юрия Геннадьевича Аляева

Cancer Urology. 2012;8(1):113
pages 113 views

ВЛАДИМИРУ НИКОЛАЕВИЧУ ЖУРАВЛЕВУ – 70 ЛЕТ

Abstract

Владимиру Николаевичу Журавлеву – 70 лет

Cancer Urology. 2012;8(1):114
pages 114 views